
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
The latest industry news, all in one place.
Clinerion has promoted Baris Erdogan to the position of Chief Executive Officer.
Mario Rocci, PhD, has joined The IMA Group as Strategic Advisor in the Clinical Research division.
Raremark appointed Nicki Grundy as Chief Financial Officer.
Parexel has appointed Dr. Clare Grace as its Chief Patient Officer.
Dr. Nick Edwards has become the Non-Executive Chair of PHASTAR.
ICON plc announced it provided clinical trial services to the Pfizer and BioNTech investigational COVID-19 vaccine program.
Veeva Systems will become a public benefit corporation on Feb. 1, 2021






